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In mammals, growth hormone-releasing hormone (GHRH) is the most important 
neuroendocrine factor that stimulates the release of growth hormone (GH) from the 
anterior pituitary. In non-mammalian vertebrates, however, the previously named 
GHRH-like peptides were unable to demonstrate robust GH-releasing activities. In this 
report, we provide evidence, for the first time, that these GHRH-like peptides are 
homologues of mammalian PACAP-related peptides (PRP).  Instead, novel GHRH 
peptides encoded in cDNAs isolated from goldfish, zebrafish and African clawed frog 
were identified.  Moreover, receptors specific for these GHRHs were characterized 
from goldfish and zebrafish. These GHRHs and GHRH-Rs are phylogenetically and 
structurally more similar to their mammalian counterparts than the previously named 
GHRH-like peptides and GHRH-like receptors. Information regarding their 
chromosomal locations and organization of neighboring genes confirmed that they 
share the same origins as the mammalian genes. Functionally, the goldfish GHRH 
dose-dependently activates cAMP production in receptor-transfected CHO cells as well 
as GH release from goldfish pituitary cells.  Tissue distribution studies showed that the 
goldfish GHRH is expressed almost exclusively in the brain, while the goldfish 
GHRH-R is actively expressed in brain and pituitary. Taken together, these results 
provide evidence for a novel GHRH-GHRH-R axis in non-mammalian vertebrates.  
Based on these data, a comprehensive evolutionary scheme for GHRH, PRP-PACAP, 
PHI-VIP genes in relation to 3 rounds of genome duplication early on in vertebrate 
evolution is proposed. The newly discovered GHRHs, also found in flounder, Fugu, 
medaka, stickleback, Tetraodon and rainbow trout, provide new research directions 




Growth hormone-releasing hormone (GHRH), also known as growth 
hormone-releasing factor, was initially isolated from pancreatic tumors causing 
acromegaly (1, 2), and hypothalamic human GHRH was shown to be identical to the 
one isolated from the pancreas tumor (3). Thereafter, the sequences of GHRHs were 
determined in various vertebrate species and in protochordates (4). In mammals, 
GHRH is mainly expressed and released from the arcuate nucleus of the hypothalamus 
(5). The primary function of GHRH is to stimulate GH synthesis and secretion from 
anterior pituitary somatotrophs via specific interaction with its receptor, GHRH-R (5). 
In addtion, GHRH activates cell proliferation, differentiation and growth of 
somatotrophs (6-8). There are many other reported activities of GHRH such as 
modulation of appetite and feeding behavior, regulation of sleeping (9-10), control of 
jejunal motility (11), and increase of leptin levels in modest obesity (12).  
In mammals, GHRH and pituitary adenylate cyclase-activating polypeptide 
(PACAP) are encoded by separate genes: GHRH is encoded with a C-peptide with no 
known function, whereas, PACAP and PACAP-related peptide (PRP) are present in the 
same transcript (13-14). In non-mammalian vertebrates and protochordates, GHRH and 
PACAP were believed to be encoded by the same gene and hence processed from the 
same transcript and prepropolypeptide (15). It was suggested that mammalian GHRH 
was evolved as a consequence of a gene duplication event of the PACAP gene which 
occurred just before the divergence that gave rise to the mammalian lineage (3). Prior to 
this gene duplication event, PACAP was the true physiological regulator for GH release 
while its function was progressively taken over by the GHRH-like peptides encoded 
with PACAP after the emergence of tetrapods (16). The GHRH-like peptide was later 
evolved to PRP in mammals, and the second copy of the ancestral GHRH-like/PACAP 
gene, after gene duplication, became the physiological GHRH in mammals (3). This 
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hypothetical evolutionary scheme of GHRH and PACAP genes previously proposed 
could successfully accommodate and explain most of the information available. 
However, by data mining of the genomic sequences from several vertebrates, genomic 
sequences encoding for putative GHRHs and GHRH-Rs from amphibian (Xenopus 
laevis) and teleost (zebrafish) were found. The corresponding proteins share a higher 
degree of sequence identity with mammalian GHRH and GHRH-R, when compared 
with the previously identified GHRH-like peptides and receptors. In this report, by 
analyzing the phylogeny, chromosomal location, and function of these ligands and 
receptors, a new evolutionary scheme for GHRH, PRP-PACAP and PHI-VIP genes in 
vertebrates is proposed. More importantly, the discovery of novel mammalian GHRH 
homologues by in silico analysis in other fish provides new research directions 
regarding the neuroendocrine control of growth in vertebrates. 
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Results 
Predicted Amino Acid Sequences of Fish and Amphibian GHRHs. Recently, 
several non-mammalian vertebrate genome databases of avian [Gallus gallus 
(chicken)], amphibian [Xenopus tropicalis. (Africa clawed frog)] and fish [Danio rerio 
(Zebrafish); Takifugu rubripes (Fugu); Tetraodon nigroviridis (Pufferfish)] species 
were completely or partially released. Using these valuable resources, we performed 
bioinformatics analyses to look for novel GHRHs and GHRH-Rs in amphibian and fish.  
Putative genes for GHRH were predicted from Xenopus tropicalis, goldfish (gfGHRH), 
and zebrafish (zfGHRH), and with the help of these sequences, we successfully cloned 
their full-length cDNAs. (supplemental data S1 to S3). By aligning all known 
vertebrate GHRH precursor sequences (S4), it was found that only the N-terminal 
region (1-27) of GHRHs is conserved. Human shares 81.5% and 74.1% sequence 
identity with goldfish/zebrafish and Xenopus laevis GHRHs, respectively (S11A). 
Within the first 7 amino acids, there is only one amino acid substitution in goat 
(position 1), human (position 1), mouse (position 1) and Xenopus (position 2). These 
observations clearly show that a strong selective pressure has acted to preserve the 
GHRH sequence in evolution, indicating that this peptide plays important functions 
from fish to mammals. It should be noted that within the first 27 amino acids, the 
previously named GHRH-like peptides share much lower level of sequence identity 
with these fish and mammalian GHRHs (51.9% - 59.3% for gfPRPsalmon, and 37% - 
44.4% for gfPRPcatfish, S5). Instead, these GHRH-like peptides are structurally 
homologous to mammalian PRPs (Fig. 1A). 
 
Cloning of GHRH-Rs from Zebrafish and Goldfish. Putative GHRH-R cDNAs 
were cloned from zebrafish and goldfish (zfGHRH-R and gfGHRH-R) (see S6 and S7). 
The amino acid sequences of these GHRH-R receptors share 78.4% identity among 
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themselves, and 51.1% and 49.7%, respectively, with the human GHRH-R (S8).  
Kyte-Doolittle hydrophobicity plots of these receptors indicated the presence of seven 
hydrophobic transmembrane regions that are conserved in all class IIB receptors (S9). 
In addition, the eight cysteine residues in the N-termini of fish and human GHRH-Rs, 
that presumably structurally maintain the ligand binding pocket (17), are identical. 
These receptors also contain the basic motifs in the third endoloop, indicating that they 
can also couple to the cAMP pathway, similar to other members in the same 
PACAP/glucagon receptor family (18).  
A comparison of the fish GHRH-R with other class IIB receptors (S11B) clearly 
shows that fish GHRH-Rs, sharing 64.8-78.4% sequence identity, are distinct from the 
previously identified GHRH-like receptors (PRP-Rs). The sequence identity between 
goldfish GHRH-R and PRP-R is 39.7%, which is not different (36.4-38.3%) from other 
goldfish receptors in the same gene family, including PAC1-R, VPAC1-R and PHI-R. 
The sequence identity shared by goldfish, avian and mammalian GHRH-Rs is 
48.9-51.1%, which is significantly higher than any other receptors in the same class IIB 
family, whether in goldfish or in human. 
 
Phylogenetic Analysis of the Novel GHRH and GHRH-Rs. Based on the novel 
GHRH sequences, a revised phylogenetic tree for GHRH, GHRH-like and PRP 
peptides was constructed using PACAP as the out-group (Fig. 1A). The newly 
identified GHRH peptides from fish and amphibian were grouped together with all 
other previously cloned or predicted GHRH sequences from mammals to fish. 
Interestingly, the previously named GHRH-like peptides were phylogenetically closer 
to mammalian PRPs and resembled to form a distinct branch together. Within the 
GHRH grouping, GHRHs clustered together according to their class with the exception 
of rodents. Within all PRPs, avian, amphibian and fish PRPsalmon-like (formerly 
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GHRHsalmon-like) clustered to form a sub-branch, whereas, the fish PRPcatfish-like 
peptides formed a different group. Apparently, there are two forms of PRPs in fish, but 
only the salmon-like PRPs are observed in avian and amphibian species. Catfish-like 
PRP, therefore, is uniquely present in fish, and hence must have evolved by gene 
duplication after the split that gave rise to tetrapod and ray-finned fish.  
Similarly, the newly found gfGHRH-R and zfGHRH-R, and the predicted 
GHRH-R from chicken and Fugu branched together with mammalian GHRH-Rs, 
whereas the fish PRP-Rs (formerly GHRH-like receptor) formed a separate branch (Fig. 
1B). These data confirmed that, together with GHRHs, receptors that are structurally 
closely related to mammalian GHRH-Rs also exist in other classes.  It is interestingly to 
note that PRP-R might have been lost in mammals (see below). As the function of PRP 
in non-mammalian vertebrates is not known, the implications of losing PRP-R in 
mammals is unclear.   
 
Chromosomal Synteny of GHRH and GHRH-R Genes. According to the latest 
genome assembly versions, the locations, gene structures and organizations of 
neighboring genes of GHRHs and GHRH-Rs in Zebrafish (zebrafish assembly version 
4, Zv4) and Xenopus (Xenopus tropicalis 4.1) were determined (S10). All exon-intron 
splice junctions agree with the canonical GT/AG rule. Both fish and amphibian GHRH 
genes have 4 exons and the mature peptides are located in exon 3. In mammals, GHRH 
genes also have 4 exons, whereas the mature peptides are found in exon 2 instead of 
exon 3. Also, exon 2 and its encoded sequences in frog and goldfish are different and 
are unique in their own species (S4). This information indicated that, although there 
were frequent exon rearrangements, the mature peptide-encoding exon, in terms of 
sequence and structure, have been relatively well preserved during evolution. Finally, 
the GHRH genes are also structurally distinct from PRP-PACAP genes (S10), in which 
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the three exons encoding cryptic peptide, PRP and PACAP are arranged in tandem. 
Thus, the organizations of GHRH and PRP-PACAP genes also indicate that they have 
different origins in evolution. 
Fig. 2 summarizes the genomic locations of GHRH and GHRH-R in various 
vertebrates. For the GHRH genes, the nearest neighboring genes of GHRH are RPN2 
and MANBAL in human and chicken. In fact, the RPN2 genes are found also in similar 
locations in all species analyzed except zebrafish (Fig. 2A). Other than RPN2, 
EPB41L1, C20orf4, DLGAP4, MYL9, and CTNNBL1 are also closely linked to the 
GHRH gene loci in human and frog. In Fugu and Xenopus, BPI and EPB41L1 genes 
are both linked to GHRH while in Fugu and zebrafish, the CDK5RAP1 gene is found 
close to the GHRH locus. These kinds of similarities in chromosomal syntenic linkage 
were not observed when comparing the GHRH and PRP-PACAP genes in vertebrate 
genomes, again confirming the idea that two different genes encoding for GHRH and 
PACAP exist from fish to mammal. 
Regarding the receptor, the GHRH-R and PAC1-R gene loci are in close proximity 
in human, chicken, zebrafish and Fugu (Fig. 2B), indicating  that they are homologues 
in different species.  Interestingly, we found that the PRP-R locus is also linked to 
PAC1-R in chicken. Despite our efforts, no PRP-R gene could be found in mammalian 
genomes (human, chimpanzee, mouse, rat and rabbit), and hence it is likely that the 
PRP-R gene was lost after the divergence that gave rise to the mammalian lineage. 
 
Comparison of Fish GHRH and PRP in Activating GHRH-R and PRP-R. To 
confirm the functional identity of fish GHRH and its receptor, zfGHRH-R-transfected 
CHO cells were exposed to 100 nM of the various related peptides (Fig. 3A). Both fish 
and frog (1-27) GHRHs were able to stimulate cAMP accumulation above background 
levels (no peptide or pcDNA3.1-transfected cells).  Graded concentrations of 
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fishGHRH and xGHRH induced dose-dependent stimulation of zfGHRH-R with EC50 
values of 3.7 x 10-7 and 8.4 x 10-7 M, respectively, the fish peptide being 2.3 folds more 
efficacious than xGHRH (Fig. 3B). In contrast, gfPRPsalmon-like and 
gfPRPcatfish-like did not induce cAMP production in zfGHRH-R-transfected cells. 
Interestingly, in gfPRP-R-transfected cells, gfPRPsalmon-like, fishGHRH, and 
xGHRH could all stimulate intracellular cAMP production dose-dependently with EC50 
values of: gfPRPsalmon-like, 5.8 x 10-9M > fishGHRH, 1.8 x 10-7M > xGHRH, 4.8 x 
10-7 M (Fig. 3C). 
To test if fish GHRH and gfPRPsalmon-like can exert a regulatory role at the 
pituitary level to modulate GH secretion, goldfish pituitary cells were challenged with 
graded concentrations of goldfish GHRH and PRP. A 4-hr incubation of cells with 
goldfish GHRH induced a dose-related increase in GH release, the minimum effective 
dose being 10 nM (Fig. 3D) whereas gfPRPsalmon-like, at concentrations up to 1 µM 
was totally inactive (Fig. 3E).  
 
Tissue Distribution of GHRH and GHRH-R in Goldfish and Xenopus laevis. The 
physiological relevance of GHRH and its cognate receptor in goldfish was tested by 
measuring their transcript levels using real-time PCR (Fig. 4). GHRH mRNA was 
detected mostly in the brain while GHRH-R mRNA was found in both brain and 
pituitary. The expression patterns of these genes in the brain-pituitary axis further 
support the functional role of the novel GHRH acting to stimulate GH release from the 
anterior pituitary.  
 
Discussion 
The Newly Identified GHRHs, but not GHRH-Like Peptides, are Mammalian 
GHRH Homologues. The primordial gene for the PACAP/VIP/glucagon gene family 
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arose more than 650 million years ago and, through exon duplication and insertion, 
gene duplication, point mutation and exon loss, the family of peptides has developed 
into the forms that are now recognized. Based on sequence comparison, phylogenetic 
study and chromosomal locations of GHRH and GHRH-R in vertebrates, we here show 
that the previously named GHRH-like peptides are homologues of mammalian PRPs, 
and hence should be renamed as PRP from now on.  Moreover, the tissue distribution of 
these PRPs in the fish brain is different when compared to mammalian GHRHs (19). 
Functionally, PRPs were unable to stimulate zfGHRH-R, as well as incapable of 
activating GH release from fish pituitary as shown in this and previous studies (20-22).   
More importantly, the present report demonstrates the presence of authentic 
GHRH peptides in non-mammalian vertebrates.  In addition to goldfish and zebrafish, 
several ray-finned fish GHRHs were identified in medaka, strickland, Fugu, Tetraodon, 
flounder, and rainbow trout (see S11) by in silico analysis. The mature GHRH 
sequences are almost identical in these eight fish species, with only one substitution in 
rainbow trout and medaka GHRHs at position 25 (S) and 26 (I), respectively. Moreover, 
the peptide cleavage sites (R and GKR) are also conserved. This information clearly 
suggests an important physiological function of GHRH in such diversified fish species, 
and shows that the newly discovered GHRHs are homologues of mammalian GHRHs. 
In parallel with the evolution of GHRHs, novel GHRH-Rs that are homologous to their 
mammalian counterparts in structure, function, chromosomal localization and tissue 
distribution are also found in fish.  We have therefore shown that, unlike what was 
hypothesized in previous reports (15-16) both GHRH and its receptor genes actually 
existed before the split for tetrapods and ray-finned fish.   
Another interesting observation is the existence of PRP-specific receptors from 
fish (23-25) to chicken, suggesting that PRP potentially is a physiological regulator in 
these species.  However, despite our efforts, we were unable to find the PRP-R gene in 
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any of the mammalian genome databases (totally 12), including the almost completed 
human and mouse genomes, indicating that PRP-R (but not PRP) was lost in the 
mammalian lineage. A possible explanation is that PRP-R was lost in a chromosomal 
translocation event. As shown in Fig. 3B, in chicken, GHRH-R, PAC1-R, PRP-R and 
VPAC1-R genes are clustered in the same chromosomal region, while, in mammals, 
VPAC1-R is translocated to a different chromosome and the DNA sequences between 
VPAC1-R and PAC1-R containing the PRP-R, somehow disappeared. 
 
Implications of the Newly Discovered GHRHs on our Understanding of the 
Evolution of GHRH and PRP-PACAP Genes. The “one-to-four” rule is the most 
widely accepted and prevalent model to explain the evolution of many vertebrate genes. 
This model is based on the “two round genome duplication” hypothesis (26). 
According to this 2R hypothesis, a first genome duplication occurred as early as in 
deuterostomes and this was followed by a second round of genome duplication, that 
took place before the origin of gnathostomes, resulting in having 4 copies of the 
genome. Based on this hypothesis and our findings, we propose a scheme for the 
evolution of GHRH and PRP-PACAP genes in vertebrates (Fig. 5). In the beginning, 
the ancestral chordates possessed one copy of the PACAP-like gene which encoded a 
single peptide, and by exon duplication, the PRP-PACAP ancestral gene was formed. 
As a result of two rounds of genome duplication (1R and 2R), the ancestral gene 
produced 4 paralogous genes, but only three of them, PRP-PACAP, PHI-VIP and 
GHRH genes, persisted in later lineages. One of the duplicated copies could have been 
lost via a global process called diploidization (27-29). Although there are two highly 
conserved PRP-PACAP genes in fish and tunicates, they are produced neither by 1R 
nor 2R, and this will be discussed later. 
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The earliest PRP-PACAP genes were identified in protochordates (Chelyosoma 
productum, 15), in which two PRP-PACAP genes with little differences in gene 
structure were found. Protochordates are invertebrates that split from vertebrates before 
the two rounds of genome duplication. Therefore, if these two PRP-PACAP genes 
existed before 1R and 2R, there should be 8 PRP-PACAP paralogues in vertebrates. 
Also, the tunicate PRP-PACAP genes share very high levels of similarity among 
themselves in terms of gene structure and peptide sequence.  Hence, these duplicated 
copies of PRP-PACAP genes are the result of a more recent gene duplication event that 
occurred after the initial divergence. Interestingly, in the phylogenetic tree, the tunicate 
PRP-like peptide belongs neither to GHRH nor to PRP groupings. The N-termini of 
these peptides are similar to PACAP, whereas the C-termini share higher similarity with 
PRP. Therefore, it is likely that these tunicate PRP-like peptides are evolved from the 
same ancestral sequences of PRP and/or PACAP.  
Based on our model, the evolution of GHRH, PRP-PACAP and PHI-VIP genes 
could be explained using the concept of Duplication-Degeneration-Complementation 
(DDC) (30-31). After the first round of genome duplication (1R), the ancestral 
PRP-PACAP gene duplicated into two and each of them independently mutated. One of 
the genes had mutations mainly in the PRP-like region, thus giving rise to the 
PRP-PACAP gene with the function of the ancestral gene mostly preserved in the 
PACAP domain. Together with PRP’s changes, a duplicated PACAP receptor evolved 
to interact specifically with PRP.  Although we have no information regarding the 
function of PRP from fish to birds, the presence of a specific receptor that is expressed 
in a tissue-specific manner strongly suggests that this peptide exerts some physiological 
role. As the primary function was secured by the conservation of PACAP, in the other 
copy, PRP is free to mutate to GHRH while PACAP sequences were lost by exon 
deletion, producing the GHRH gene in vertebrates. After 2R, the duplicated gene copy 
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for PRP-PACAP was free to mutate and hence to acquire new functions to become 
PHI-VIP, and consistently, PHI and VIP are similar to PRP and PACAP, respectively. 
Until now, we have not been able to find a second GHRH homologue in vertebrates, 
and we thus propose that the duplicated GHRH gene may have been deleted or lost in 
the process of genome rediploidization.  
The final question is what is the origin of the two forms of PRP, salmon-like and 
catfish-like, and correspondingly two PRP-PACAP genes, in fish? We named these 
PRPcatfish-like and salmon-like as there are clearly two branches in the phylogenetic 
tree in which the avian and amphibian PRPs are more similar to fish PRPsalmon-like. 
Based on previous reports and sequence analysis, we found that, in fact, all bony fish 
possess a PRPsalmon-like gene, supporting the idea that PRPsalmon-like is the 
ancestral form while PRPcatfish-like existed before the tetrapod/fish split, a duplicated 
copy arising from a more recent duplication event that occurred after the appearance of 
the teleost lineage (32). This is confirmed by the presence of duplicated PHI-VIP and 
glucagon genes in the Fugu and zebrafish genomes, as well as two genes for PAC1-R, 
VPAC1-R and VPAC2-R in fish (33). There is further evidence supporting the 
hypothesis of a third round of genome duplication; for example, zebrafish possesses 
seven HOX clusters on seven different chromosomes, instead of four clusters found in 
mammals (34). Also, there are many duplicated segments in the zebrafish genome 
where similar duplication are not found in the mammalian genome. This information 
suggests that some of the genome was duplicated in an ancient teleost. Based on this, 
we hypothesize that catfish-like and salmon-like PRP encoding genes were produced 
from the actinopterygian-specific genome duplication at around 300-450MYA.  
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Materials and Methods 
Animals and Peptides. Zebrafish and goldfish were purchased from local fish markets, 
and Xenopus laevis was bought from Xenopusone Inc. Mi. Peptides including X. laevis 
GHRH (xGHRH), zebrafish or goldfish GHRH (fish GHRH), goldfish PRPsalmon-like 
(previously gfGHRHsalmon-like, 24), and goldfish PRPcatfish-like (previously 
gfGHRHcatfish-like, 24) were synthesized by The Rockefeller University. 
 
Data Mining and Phylogenetic Analysis. By searching genome databases (Ensembl 
genome browse and NCBI database) of chicken (Gallus gallus), Xenopus (Xenopus 
tropicalis), zebrafish (Danio rerio) and Fugu (Fugu rubripes), putative GHRH and 
GHRH-R sequences were found. These sequences were used for phylogenetic analyses 
by MEGA3.0 to produce neighbor-joining (NJ) trees with Dayhoff matrix (35). 
Predicted protein sequences were then aligned by ClustalW. Sequence-specific or 
degenerate primers were designed accordingly for cDNA cloning by PCR 
amplifications.  
 
Molecular Cloning of GHRHs (Xenopus laevis, Zebrafish and Goldfish) and 
GHRH-Rs (Zebrafish and Goldfish). Total RNAs from brain (zebrafish and goldfish) 
and pituitary (Xenopus laevis) were extracted according to the manufacturer’s protocol 
(Invitrogen, Carlsbad, CA). Rapid Amplification of cDNA Ends (5’ and 3’ RACE) was 
performed using the 5’ and 3’ RACE amplification kits (Invitrogen). Full length cDNA 
clones encompassing the 5’ to 3’ untranslated regions were produced by PCR using 
specific primers and confirmed by DNA sequencing.  Full-length GHRH-R cDNAs 
were subcloned into pcDNA3.1+ (Invitrogen) for functional expression. Primers used 
in this study are listed in S12. 
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Tissue Distribution of GHRH and GHRH-R in Goldfish. Goldfish GHRH and 
GHRH-R transcript levels in various tissues were measured by real-time RT-PCR. First 
strand cDNAs from various tissues of sexually matured goldfish were prepared using 
the oligo-dT primer (Invitrogen). GHRH and GHRH-R levels were determined using 
the SYBR Green PCR Master Mix kit (Applied Biosystems, Foster City, CA) together 
with specific primers (sequences listed in S13). Fluorescence signals were monitored in 
real time by the iCycler iQ system (Bio-Rad, Hercules, CA). The threshold cycle (Ct) is 
defined as the fractional cycle number at which the fluorescence reaches 10-fold 
standard deviation of the baseline (from cycle 2 to 10). The ratio change in target gene 
relative to the E-actin control gene was determined by the 2-''Ct method (36). 
 
Functional Studies of Fish GHRH-R and PRP-R. For functional studies, zfGHRH-R 
cDNA in pcDNA3.1 (Invitrogen) was permanently transfected into Chinese Hamster 
Ovary (CHO) cells (ATCC, Manassas, VA) using the Genejuice reagent (Novagen, 
Darmstadt) and followed by G418 selection (500 ȝg/ml) for 3 weeks. Several clones of 
receptor-transfected CHO cells were produced by dilution into 96-well plates. 
Following RT-PCR to monitor the expression levels of individual clones, colony with 
the highest expression was expanded and used for cAMP assays. A 
gfPRP-R-transfected (previously gfGHRH-R, 25) permanent CHO cell-line was also 
used for comparison in functional expression studies. 
To measure cAMP production upon ligand activation, 2 days prior to stimulation, 
2.5 x 105 CHO-zfGHRH-R or CHO-gfPRP-R cells were seeded onto 6-well plates 
(Costar, CA). The assay was performed essentially as described earlier (37) using the 
Correlate-EIA Immunoassay Kits (Assay Design, Mi). 
 
Measurement of GH Release from Goldfish Pituitary Cells. Goldfish in late stages 
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of sexual regression were used for the preparation of pituitary cell cultures. Fish were 
sacrificed by spinosectomy after anesthesia in 0.05% tricane methanesulphonate 
(Syndel, Vancouver, BC, Canada).  Pituitaries were excised, diced into 0.6 mm 
fragments, and dispersed using the trypsin/DNA II digestion method (38) with minor 
modifications (39).  Pituitary cells were cultured in 24-well cluster plates at a density of 
0.25 u 106 cells/well.  After overnight incubation, cells were stimulated for 4 hr and 
culture medium was harvested for GH measurement using a radioimmunoassay 
previously validated for goldfish GH (40). 
 
Data Analysis. Data from real time PCR are shown as the means r SEM of duplicated 
assays in at least three independent experiments. All data were analyzed by one-way 
ANOVA followed by a Dunnett’s test using PRISM (version 3.0, GraphPad Software 
Inc., San Diego, CA). 
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Fig. 1. Phylogenetic analysis of GHRH, PRP and GHRH-like peptide (1-27), 
GHRH-Rs and PRP-Rs. Predicted peptide and receptor sequences are marked with 
asterisks. (A) PACAP sequences were used as an out-group. (B) Novel receptors 
identified in this report are underlined.  
 
Fig. 2. Chromosomal locations of GHRH and GHRH-R in various vertebrate species. 
Genes adjacent to GHRH and GHRH-R in different genomes are shown. The genes are 
named according to their annotation in the human genome. GHRH and GHRH-R genes 
are boxed 
 
Fig. 3. Functional assays. (A) Intracellular cAMP accumulation in CHO-zfGHRH-R 
cells stimulated with 100 nM peptides: fish GHRH, Xenopus GHRH, goldfish 
PRPsalmon–like, goldfish PRPcatfish-like, goldfish PHI, goldfish glucagon, zebrafish 
GIP, human PACAP-27 and human PACAP-38; (B,C) Effect of graded concentrations 
(from 10-11 to 10-5 M) of various GHRHs and gfPRPs on cAMP accumulation in 
CHO-zfGHRH-R cells (B) and CHO-gfPRP-R cells (C). Values represent means ± S.E 
from 3 independent experiments each in duplicates. Effect of graded concentrations 
(from 10-11 to 10-6 M) of (D) fishGHRH and (E) gfPRPsalmon-like on GH release from 
cultured goldfish pituitary cells. Cells were incubated for 4 hrs with fishGHRH (D, 
n=12) or gfPRPsalmon-like (E, n=4). Values represent means ± S.E.M. from at least 
two experiments performed in duplicate. 
 
Fig. 4. Relative abundance of (A) GHRH and (B) GHRH-R transcripts in different 
tissues in goldfish. A relative abundance of 1 was set arbitrarily for both genes in the 
 21
brain. Data are from at least 3 experiments performed in duplicate. Values are expressed 
as means r SEM. 
 
Fig. 5. A proposed evolutionary scheme of GHRH, PRP-PACAP, PHI-VIP genes with 
respect to several rounds of genome duplication. Labeling of peptides and gene 
organizations are shown in the legend. The genome duplication events are highlighted 
by light blue boxes. Unknown or unclear paths are marked with question marks. Time 
for divergence in MYA was taken from (41).  
Figure 1





















Xenopus tropicalis GHRH* 
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Pituitary adenylate cyclase-activating polypeptide -
PACAP related peptide
Vasoactive intestinal polypeptide




1 actacaatca ccaacagtag aggctgggaa taaaatcaaa tcctcagtga
51 gagaaagatc ttgtttccgt cacatttgtt acaaacctgg accagaaatc
M   Q  V  G   V  I  Q  R   T  A  L   L  V  L 
101 tttgatcATG CAAGTGGGAG TAATTCAGAG AACTGCCTTG CTAGTGCTAT
C  C  L  L   L  S  A   S  S  S   P  V  Y  P   A  L  K
151 GCTGCTTGTT ACTATCAGCA TCATCTTCCC CAGTCTACCC AGCACTGAAG
F  G  R   H  A  D  A   I  F  T   N  S  Y   R  K  V  L
201 TTTGGAAGAC ATGCTGATGC CATCTTTACC AACAGCTACA GAAAAGTTCT
G  Q  I   S  A  R   K  F  L  Q   T  V  M G  K  R
251 TGGTCAAATA TCTGCCAGAA AATTTCTTCA AACTGTTATG GGAAAAAGAC
L  G  P  E   T  E  S   N  V  K   R  Q  S  S   M  Y  G
301 TTGGACCAGA AACTGAAAGC AATGTAAAGC GTCAGTCAAG TATGTATGGA
N  T  Y   K  Q  D  V   D  M  N   V  I  E   S  E  Q  S
351 AACACCTACA AGCAAGATGT GGACATGAAT GTCATTGAGA GTGAACAAAG
Y  R  D   P  Q  K   F  K  F  A   L  I  M   H  *
401 TTACAGAGAC CCACAAAAAT TTAAGTTTGC ATTAATTATG CACTGAatta
451 aaatgtaaag tgcatataca ttatgaatat ttaaaaggga actattgcat
501 ttgctgtatt tcatattgga taattaaaac tcacccatgt tataatc
Figure S1 cDNA and predicted amino acid sequences of zfGHRH. The numbers on the 
left are the positions of the nucleotide sequences. The UTR sequences are in lower case. 
The coding sequences are in upper case. The mature peptide sequence is highlighted in 
bold letter. Potential peptide cleavage sites are in open boxes. Stop codon is represented 
by an asterisks.The zfGHRH cDNA encompasses a 107-bp 5’ UTR, a 339-bp open 
reading frame (ORF) encoding a 113-amino acid protein, and a 101-bp 3’ UTR. The 
predicted prepro-zfGHRH has a putative 23-amino acid signal peptide and potential 
peptide processing sites R and GKR at position 34 and 62-64, respectively, suggesting 
the 27-amino acid zfGHRH is located between 35 to 61.
Supplemental data
Figure S2
1 ctcttattca gcatcgggaa gaatgaaacc aaaccctgag tgagagcgac
51 aacatctcat gtctttgttc agtagactga ggagcacatc accaatcaca
M  Q  R   V  A  M   L  L  F   C  C  L  L
101 caagtgagaa tgATGCAGAG AGTTGCCATG CTATTGTTCT GCTGCCTGTT
L  S  A   T  S  S   P  V  Y   P  L  R  F   G  Q  R    
151 ACTTTCAGCG ACATCTTCCC CAGTCTATCC ACTAAGGTTC GGTCAGAGAG
A  A  A  I   L  M  T   S  S  I   E  D  P  M   Q  L  P
201 CGGCTGCGAT ACTGATGACC TCCTCTATTG AGGATCCAAT GCAGTTGCCA
A  D  T   S  S  Q  T   P  D  A   E  F  R   F  G  R  H
251 GCAGACACTT CATCCCAAAC ACCAGATGCT GAGTTTAGGT TTGGGAGACA
A  D  A   I  F  T   N  S  Y  R   K  V  L   G  Q  I
301 TGCTGACGCC ATCTTTACCA ACAGCTACCG AAAAGTTCTT GGTCAAATAT
S  A  R  K   F  L  Q   T  V  M G  K  R L   G  P  E 
351 CTGCCAGAAA ATTCCTTCAA ACTGTTATGG GCAAAAGACT TGGACCAGAA
T  Q  N   Y  V  K  R   H  S  G   I  Y  G   D  T  F  N
401 ACTCAAAACT ATGTGAAACG CCACTCTGGC ATATATGGAG ACACCTTCAA
Q  D  V   D  M  D   V  I  E  R   E  Q  S   Y  R  E  
451 TCAAGATGTG GATATGGATG TAATTGAAAG AGAACAAAGT TACAGAGAAC
P  Q  R  L   K  F  S   V  V  T   Q  *
501 CACAACGACT TAAGTTCTCA GTAGTTACAC AATGAttaaa gattaatcat
551 tagtcaataa actgcgaaca atctttatac ttacatttgc cacatttcac
601 actggattat taaatctaag ttcagccttc gt
Goldfish GHRH
Figure S2 cDNA and predicted amino acid sequences of gfGHRH. The numbers on the 
left are the positions of the nucleotide sequences. The UTR sequences are in lower case. 
The coding sequences are in upper case. The mature peptide sequence is highlighted in 
bold letter. Potential peptide cleavage sites are in open boxes. Stop codon is represented 
by an asterisks. The sizes of the 5’UTR, ORF and 3’UTR are 112, 420, and 97-bps, 
respectively, and, within the ORF, the predicted GHRH sequences between the putative 
cleavage sites (R and GKR, position 62 and 90-92) are identical to those of zfGHRH. As 
both fish GHRHs are followed immediately by GKR, they are likely D-amidated at the C-
termini.  
Figure S3
1 aatttcgcag accctccggc tgtaaggatt ctacagcttt gggaagcacg
51 ccattgtaga ggaagaagtt cagcaggact gactacacag tttttactgc
M  R  R   T  L  C   L  L  L  L   H  F  A
101 aaaaaaagaa ggATGCGCAG AACACTTTGC CTGTTGCTAC TCCATTTTGC
L  C  V   Q  C  Y   I  F  H  P   K  Y  S   S  Y  Q  
151 ATTATGTGTG CAGTGTTACA TCTTTCATCC AAAATACAGT TCTTACCAGA
T  P  G  D   F  N  I   E  T  I   E  P  L  Q   S  Q  D
201 CTCCAGGCGA CTTTAATATC GAGACAATTG AGCCCTTGCA AAGCCAAGAC
W  S  S   L  D  E  K   K  E  Y   V  R  G   L  S  E  N
251 TGGTCATCTT TGGATGAGAA AAAGGAATAT GTCAGGGGAC TGTCAGAAAA
R  V  E   R  H  V   D  A  I  F   T  N  T   Y  R  K
301 CAGGGTGGAA CGGCATGTGG ATGCCATATT CACTAACACA TACAGAAAAT
F  L  G  Q   I  S  A   R  R  Y   L  Q  N  M   M G  K
351 TCCTGGGGCA GATTTCAGCC AGGAGGTACC TGCAGAACAT GATGGGGAAA
T  L  G  Q   D  T  Q   K  K  A   D  P  E   D  G  V  L
401 ACCCTGGGGC AGGATACCCA GAAAAAGGCA GATCCTGAAG ATGGTGTGCT
G  E  E   V  I  T   L  L  S  D   S  G  I   P  D  W  
451 GGGGGAAGAA GTGATCACCC TACTGAGTGA CAGTGGGATT CCAGATTGGA
R  A  E  E   H  R  E   T  R  L   *
501 GGGCAGAAGA GCACCGTGAG ACCCGGCTAT AAactagaag cctacaggat
551 ccgtcatcaa atgttcagcc taatgcgtta attccgtgcc aacaaaatgg
601 acagcaatgg caacatacat gatagagcat tggtcattgt gatttctgag
651 ttggtaataa aatataacat tatggggcaa aaaaaactag gtcaagtttt
701 atgccaattc cctgttgaga aaaatcactt tttgcatcta atcaagaagc
751 agttgtacag aggtatttca taaaataaaa agttttagtg
X. laevis GHRH
Figure S3 cDNA and predicted amino acid sequences of xGHRH. The numbers on the left 
are the positions of the nucleotide sequences. The UTR sequences are in lower case. The 
coding sequences are in upper case. The mature peptide sequence is highlighted in bold 
letter. Potential peptide cleavage sites are in open boxes. Stop codon is represented by 
an asterisks. Xenopus laevis GHRH cDNA is 790 bps in length with a 112-bp 5’UTR, a 
420-bp ORF and a 258-bp 3’ UTR (supplemental data S3). Within the 140-amino acid 
xGHRH precursor protein, the N-terminal processing site (R at position 67) is conserved 
while the C-terminal site (GKT at position 95-97 or KK at position 104-105) is unclear. The 
mature xGHRH peptide may be 27- or 28-amino acid long, depending whether G at 95 is 





Figure S4 Alignment of GHRH precursor proteins. The alignment was generated 
by using the default settings of the VectorNTI 10 (Invitrogen) with AlignX
program. Identical and conserved residues are highlighted in red and blue, 
respectively. Putative GHRH peptides are in the open box. Regions found only in 





























Figure S5 Percentage similarity and identity of gfGHRH with other GHRHs. 
Chromosomal locations of GHRHs in species not yet determined are labeled as 
unknown. In the alignment, conserved and identical residues for GHRH and PRP 
are highlighted in blue and red, respectively. Residues that are conserved in 
PRP are labeled in green. The % identity was calculated by comparing with 
gfGHRH. Sf, scaffold number; Ch, chromosome number; --, sequences isolated 
in this report; *, sequences predicted from the genome database.
Species Position Sequences (1-27) %Identity Ref
GHRH
Goldfish Unknow HADAIFTNSYRKVLGQISARKFLQTVM 100 --
Zebrafish Ch11 HADAIFTNSYRKVLGQISARKFLQTVM 100 --
Fugu Sf 701 HADAIFTNSYRKVLGQISARKILQTIM 92.6 *
Tetraodon Ch11 HADAIFTNSYRKVLGQISARKILQTIM 92.6 *
X. laevis Unknow HVDAIFTNTYRKFLGQISARRYLQNMM 74.1 --
X. tropicalis Sf 637 HVDAIFTNTYRKFLGQISARRYLQNMI 70.4 *
Chicken Ch20 HADAIFTDNYRKFLGQISARKFLQTII 81.5 *
Rat Ch3 HADAIFTSSYRRILGQLYARKLLHEIM 63.0
Mouse Ch2 HVDAIFTTNYRKLLSQLYARKVIQDIM 59.3
Goat Unknow YADAIFTNSYRKVLGQLSARKLLQDIM 81.5
Human Ch20 YADAIFTNSYRKVLGQLSARKLLQDIM 81.5
PRP
Goldfish-catfish Unknow HADGLLDRALRDILVQLSARKYLHSLM 44.4
Goldfish-salmon Unknow HADGMFNKAYRKALGQLSARHYLHTLM 59.3
Chicken HADGIFSKAYRKLLGQLSARKYLHSLM 66.7
X. laevis HADELLNKVYRNVLGHLSARKYLHTLM 40.7
Mouse VAHEILNEAYRKVLDQLSARKYLQSVV 55.6











M  L   P  C  A  R   G  L  F   W  L  L   T  C  L  T
1 gcgctgtgga ctcgactgga gagATGCTGC CGTGTGCGCG TGGACTTTTC TGGCTGCTGA CATGTCTCAC
T  V  L   C  S L   H  P  E  C   E  Y  I   F  Q  L   A  R  D  E   Q  R  C
71 AACTGTGTTG TGTAGTTTGC ATCCCGAGTG TGAATATATC TTTCAGCTGG CGAGAGATGA ACAGCGGTGT
L  R  E   I  T  D  L   G  N L   S  S  S   S  G  C  L   S  V  W   D  S  V
141 CTGCGAGAGA TCACAGATCT GGGGAACCTC AGCAGCTCCT CAGGTTGTCT TTCAGTATGG GATTCAGTGG
V  C  W  P   S  A  V   V  G  E   T  V  Q  S   P  C  P   A  V  F S  L  F  E
211 TCTGCTGGCC CAGTGCTGTG GTGGGTGAAA CTGTCCAGTC TCCCTGTCCT GCTGTTTTCT CTCTCTTCGA
N  N  T   E  G  V   V  S  R  N   C  T  V   T  G  W   S  R  P  F   P  P  Y
281 GAACAACACA GAAGGTGTAG TGAGTCGAAA CTGCACAGTC ACAGGCTGGT CCCGACCGTT TCCTCCTTAT
H  V  A   C  S  A  E   D  N  I   P  E  E   S  Y  F  A   T  V  K   L  I  Y  
351 CATGTGGCCT GCAGCGCTGA GGACAATATC CCAGAGGAGT CGTATTTTGC CACTGTGAAG CTGATCTACA
T  V  G  Y   G  A  S   L  L  S   L  S  V  A   V L  I   L  L  L   F  R  R  L
421 CTGTGGGCTA TGGAGCATCT CTGCTCTCGC TCTCTGTTGC TGTGCTAATA CTGCTGCTCT TCAGGCGACT
H  C  T   R  N  Y   I  H  M  Q   L  F  F   T  F  I   L  K  S  V   A  V  F
491 GCACTGCACT CGAAACTATA TCCACATGCA GCTGTTTTTC ACCTTCATCC TGAAATCTGT GGCCGTGTTC
I  K  D V  T  L  F   S  S  D   D  T  D   H  C  S  L   S  T  V   A  C K  
561 ATCAAAGATG TGACGCTGTT CTCCAGCGAC GACACAGATC ACTGCTCTCT GTCTACTGTG GCCTGTAAAA
T  A  V  V   F  C  H   Y  C  V   M  S  N  F   F  W  L   L  V  E   A  V  Y  L
631 CAGCGGTGGT GTTTTGTCAC TATTGCGTCA TGTCTAATTT CTTCTGGTTG CTGGTTGAAG CTGTGTATCT
N  S  L   L  V  S   V  F  L  R   R  R  R   C  L  W   A  F  A  L   L  G  W
701 GAACTCTCTG CTGGTGTCCG TGTTTCTGCG CAGACGCCGC TGTCTGTGGG CTTTTGCTCT GTTGGGCTGG
G  V  P   L  V  C  I   V  L  W I  F  S   R  L  Y  F   E  D  T   E  C  W  
771 GGTGTTCCAC TGGTCTGCAT TGTCCTTTGG ATCTTCTCCA GACTGTATTT TGAAGACACT GAATGCTGGG
D  I  N  E   D  S  P   Y  W  W   I  I  K  G   P  I  V   I  S  I   A  V  N  F
841 ACATAAATGA AGATTCTCCT TATTGGTGGA TCATAAAGGG CCCCATTGTA ATATCTATTG CGGTGAACTT
L  L  F   L  N  I   I R  I  L   M  Q  K   L  N  P   R  L  I  Q   F  N  N
911 TCTTCTCTTC TTGAACATTA TCAGGATTCT GATGCAGAAA CTGAACCCTC GCTTGATCCA GTTCAACAAT
S  D  Q   Y  R  R  L   T  K  S   T  L  L   L  I  P  L   F  G  T   H  Y  M
981 TCAGACCAGT ACAGGCGACT GACCAAGTCC ACACTCCTGC TCATCCCTCT CTTCGGCACT CATTACATGA
I  F  S  F   L  P D   Y  F  N  T   G  L  R   L  C  I   E  L  C   L  G  S  F
1051 TCTTCAGCTT TCTCCCAGAC TACTTCAACA CGGGCTTGCG GCTCTGCATT GAGCTGTGTC TGGGCTCCTT
Q  G  L   I  V  A  I   L  Y  C   F  L  N   Q E  V   Q  N  E  I   R  L  R
1121 CCAGGGCCTG ATTGTGGCAA TTCTCTACTG TTTCCTGAAC CAGGAGGTTC AGAATGAGAT ACGGTTACGA
W  L  R   Y  Q  E  G   S  Y  A   V  V  P   V  G  V  K   G  S  Q M  D  T  
1191 TGGCTTCGGT ATCAAGAAGG AAGTTATGCT GTCGTCCCCG TCGGAGTGAA AGGAAGTCAG ATGGACACTC
P  V  H  R   Q  T  R   R  N  S   I  K  H  F   T  V  C   I  L  F C  S  F  Y
1261 CAGTCCACCG TCAAACCAGA AGAAATTCAA TCAAACATTT TACCGTATGC ATATTGTTTT GCTCTTTTTA
M  T  T   I  G  L   K  G  T  *
1331 TATGACAACA ATTGGCTTAA AGGGGACCTA Atatgcacat ttttacaaga tctaaaataa gtctctggta
1401 tccctaaagt gcgcatgtga agtttcagct caaaatacca cacaaatgat gttttataac ttattaaaac
1471 ggatcccttt aagctttgat tctaattgtg gcattttggt gactgtcgct ttaaattca
Zebrafish GHRH ReceptorFigure S6
Figure S6 cDNA and predicted amino acid sequences of zebrafish GHRH-R. 
The seven transmembrane domains are underlined. The RLTK motif is boxed. 
The conserved cystine residues at the N-terminal are circled. The putative 
signal peptide is in bold letter. The stop codon is represented by an asterisk. 
The N-glycosylation site is marked in a black box.
Goldfish GHRH Receptor
M   T  G  D  M   R  S  W   A  R  G   I  L  W  L   S  S  F
1 agcgcgcgct gtggacATGA CTGGAGACAT GCGCTCGTGG GCTCGCGGGA TCCTGTGGTT GTCATCTTTT
T  T  V   L  S S  L   H  P  E   C  E  Y  I   F  Q  L   A  R  D   E  Q  R
71 ACAACTGTGT TGTCTAGTTT GCATCCTGAG TGTGAGTATA TCTTTCAGCT GGCAAGAGAT GAGCAGCGGT
C  L  R  E   I  T  D   L  G  N  L  S  S  S   S  G  C   L  P  V   W  D  A  V 
141 GTCTCAGAGA GATCACAGAT CTTGGAAACC TCAGCAGCTC TTCAGGTTGT CTGCCAGTAT GGGATGCTGT
V  C  W   P  R  A   A  V  G  E   T  I  H   L  L  C   P  A  V  F   S  L  F
211 AGTGTGTTGG CCCAGAGCTG CAGTGGGTGA GACGATCCAC TTGCTGTGTC CTGCTGTTTT CTCTCTCTTC
K  N  N   T  G  I  V   S  R  N   C  T  A   G  G  W  S   H  P  F P  P  Y  
281 AAGAACAACA CAGGTATAGT GAGTCGTAAC TGCACGGCTG GCGGCTGGTC ACATCCGTTC CCTCCGTACC
H  E  A  C   I  V  E   D  E  I   P  E  E  S   Y F  F   T  V  K   L  I  Y  T
351 ACGAGGCCTG CATTGTTGAG GACGAAATCC CAGAGGAGTC GTATTTCTTC ACTGTGAAAC TGATCTACAC
V  G  Y   G  A  S   L  L  S  L   S  V  A   V A  I   L  M  L  F   R  R  L
421 TGTTGGATAC GGAGCATCAC TGCTGTCGCT CTCTGTTGCC GTGGCAATAC TGATGCTCTT CAGGCGATTA
H  C  A   R  N Y  I   H  M  Q   L  F  F   T  F  I  L   K  S  V   A  V  F__
491 CACTGCGCTC GAAACTATAT CCACATGCAG CTGTTTTTCA CCTTCATCCT GAAATCGGTG GCTGTGTTTA
I  K  D A   T  L  F   S  S  D   D  T  D  H   C  S  L   S  R  T   A  C  K  A 
561 TCAAAGATGC TACGCTGTTC TCCAGTGACG ACACAGATCA CTGCTCTCTC TCCAGAACGG CCTGTAAGGC
A  V  V  F  C  H   Y  C  I  M   T  N  F   F  W  L   L  V  E  A   V  Y  L_
631 AGCGGTGGTA TTTTGTCATT ACTGTATCAT GACTAATTTC TTCTGGTTGC TGGTTGAAGC CGTGTATCTG
N  S  L   L  V  S  D   F  P  R   S  R  R C  L  W  T   F  A  L   L  G  W__
701 AACTCTCTGC TGGTCTCAGA CTTCCCGCGC AGCCGCCGCT GTCTCTGGAC TTTCGCTCTG CTGGGCTGGG
G  F  P  L   V  C  I   V  L  W I  C  S  R   L  Y  F   E  D  T   E  C  W  N
771 GCTTTCCACT GGTTTGCATT GTCCTCTGGA TCTGTTCCAG ACTGTATTTT GAAGACACAG AGTGCTGGAA
I  N  E   D  S  P   Y W  W  I   I  K  G   P  I  V   V  S  I  G   M  N  F_
841 CATAAATGAA GACTCTCCTT ATTGGTGGAT CATCAAGGGT CCCATTGTAG TTTCCATAGG GATGAACTTC
L  L  F   M  N  I  I  R  I  L   V  Q  K   L  N  P  R   L  I  Q   F  N  N  
911 CTTCTCTTCA TGAACATTAT CAGGATTCTG GTGCAGAAAC TGAACCCTCG CTTGATCCAA TTCAACAATT
S  A  Q  Y   R  R  L   T  K S   T  L  L  L   I  P  L   F  G  T   H  Y  M  V
981 CAGCTCAGTA CAGGCGACTG ACCAAGTCCA CCCTCCTCCT CATCCCTCTC TTCGGCACTC ATTACATGGT
F  N  F   L  P  D Y  F  N  V   S  L  R   L  C  I   E L  C  L   G  S  F_
1051 CTTCAACTTC CTCCCAGACT ACTTCAACGT GAGCCTGCGG CTTTGCATCG AGCTGTGTCT GGGCTCCTTC
Q  G  L   I  V  A  V   L  Y  C   F  L  N Q  E  V  Q   K  E  I   R  L  R  
1121 CAGGGCCTCA TTGTGGCAGT TCTCTACTGT TTCCTGAACC AGGAGGTTCA GAAAGAAATA CGCTTACGTT
W  M  R  Y   Q  E  G   S  Y  I   V  V  P  V   G  A  K   G  S  Q M  D  T  P 
1191 GGATGCGATA TCAAGAGGGG AGTTACATTG TCGTCCCTGT TGGAGCCAAA GGAAGTCAAA TGGACACTCC
F  *
1261 ATTCTAGagt cattaaaatt caccggtgcc tctaatatac agacctcaac acctccagaa accatgaaca
1331 tctgaatcca acagttttat ttaatacaga ttgtattgct cagtcgatat gacaacaaat ggcttaaaca
1401 gccagaatat acagtatttg ggctgcagta tatctgtgaa ttaacacact taacagagtt cattagagag
1471 catggtaaaa atgtgcaatt catcagaaca aaactgctgc ttttgggggt ttcttggtgg gtttaattaa
1541 agtatgtaca tatatagaga aaagcctatc aaaatatact actgctgccc ttcaaattat ttattacttt
1611 aaggggnaat gttaaactga gatatgacag ttttgaatgt gtatgtattt agctgtatgt atgtacatgt
1681 ttacagtatt aacattggta aagagaaata ttaagatttt tgagtgagat aggcctacag gtaaccaggc
1751 aagttatgtt ttatatgttt attctgccaa atttgttact tcacttcgat tggcaaaaca gtggtttgat
1821 atttccttat catttcacaa gttgctttgt gtttttaact gtatttatat tttgctgaaa cgcctgttat
1891 aggctgttta atcaatgtca agttccctta gtgtgacaac acgcctgcaa tttgctcatc atatgttcct
1961 gtatctttcc ccctgtcata tacatgttca aaatcatatt tgtagcaaag acccactctc aaaatgacta
2031 ttttgagcta aaggagtgta acaactggcc ctggtttctc ctttctgctg cttgattctt ttatttttaa
2101 tacttaaaaa tgacattagt att
Figure S7
Figure S7 cDNA and predicted amino acid sequences of goldfish GHRH-R. 
The seven transmembrane domains are underlined. The RLTK motif is boxed. 
The conserved cystine residues at the N-terminal are circled. The putative 
signal peptide is in bold letter. The stop codon is represented by an asterisk. 



























Figure S8 Percentage similarity and identity of gfGHRH-R with other GHRH 




















































Goldfish PRP-R ZebraF PRP-R*





















-----WTTPSRSAAKVLTSMC----------------------------TSDITEAQKKLRKRQRMREQKKLKQQNLLL--------- Highly Conserved in GHRH-R






























































Figure S9. Amino acid alignment of GHRH-Rs and PRP-Rs. The alignment was generated by using the default 
settings of the VectorNTI 10 (Invitrogen) with AlignX program. Conserved residues for both GHRH-R and PRP-R 
are highlighted in blue. Residues that are conserved only among GHRH-Rs are in red. Residues conserved in fish 
and chicken GHRH-Rs are in green. Putative transmembrane domains (TM1 to TM7) are in open blue boxes. *, 
conserved cysteine residues.
Figure S10
Figure S10 Diagrammatic representation of GHRH and PRP-PACAP gene 
structures in various vertebrates. The boxes represent exons. The solid lines 
represent introns.  Different domains of the precursors are shown in the legend.
ZebrafishGHRH
Xenopus GHRH
































































Genome (NCBI)PredictedPredictedChicken (Gallus gallus)
GenBank (NCBI)P07217NoneSheep (Ovis aries)
Genome (ENsembl)PredictedPredictedElephant
GenBank (NCBI)P63293NoneGoat (Capra hircus)
GenBank (NCBI)P01287NonePig (Sus scrofa)
















































































































Predicted – Sequence is predicted from genome database
None – No sequence is available
Ch – Chromosome Number
Sf – Scaffold Number
A – Automatic prediction from genome project
Figure S12
Primer sequences used in PCR cloning of GHRH and GHRH-R cDNAs
Figure S13
PCR primers for real-time analysis of goldfish GHRH and GHRH-R
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